Humoral response to Pfizer mRNA vaccine against SARS CoV2, in patients with autoimmune inflammatory rheumatic diseases and the impact on the rheumatic disease activity

Yolanda Braun-Moscovici, Marielle Kaplan, Doron Markovits, Samy Giryes, Kochava Toledano, Yonit Tavor, Katya Dolnikov, Alexandra Balbir-Gurman
doi: https://doi.org/10.1101/2021.04.02.21254493

Article usage

Article usage: April 2021 to December 2024

AbstractFullPdf
Apr 2021293942518
May 202184520180
Jun 202110684167
Jul 2021114515171
Aug 202110127162
Sep 20211861108
Oct 2021151881
Nov 2021127281
Dec 2021136041
Jan 2022117640
Feb 202251028
Mar 202260422
Apr 202262418
May 202252019
Jun 2022522101
Jul 202241280
Aug 202240110
Sep 202253015
Oct 20223207
Nov 20222005
Dec 202234115
Jan 202331012
Feb 202328331
Mar 202343013
Apr 20232619
May 20231416
Jun 2023847
Jul 20231014
Aug 2023251210
Sep 20232048
Oct 20232129
Nov 202324514
Dec 20231906
Jan 20241318
Feb 202417315
Mar 202413111
Apr 20248313
May 20241237
Jun 20242717
Jul 20241428
Aug 202421615
Sep 20242317
Oct 2024715
Nov 20241919
Dec 2024201
Back to top
Posted April 06, 2021.
Download PDF
Data/Code
Email
Humoral response to Pfizer mRNA vaccine against SARS CoV2, in patients with autoimmune inflammatory rheumatic diseases and the impact on the rheumatic disease activity
Yolanda Braun-Moscovici, Marielle Kaplan, Doron Markovits, Samy Giryes, Kochava Toledano, Yonit Tavor, Katya Dolnikov, Alexandra Balbir-Gurman
medRxiv 2021.04.02.21254493; doi: https://doi.org/10.1101/2021.04.02.21254493
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area